Brexit

Views & Analysis

UK Leaders: Gilead's Hilary Hutton-Squire on building trust ...

As general manager of Gilead UK and Ireland, Hilary Hutton-Squire has been at the forefront of bringing several innovative medicines to the NHS.

Market Access

Pharma industry body urges “ambition” in UK-EU trade talks

News

Dutch biotech sector feel benefits of EMA move, says industr...

The Netherlands’ biotech sector has already seen an upswing following the relocation of the European Medicines Agency (EMA) to Amsterdam following Brexit, according to an influential figure

Views & Analysis

Sanofi Genzyme UK medical boss Marc Moodley discusses oncolo...

Marc Moodley has worked at Sanofi since 2018 and is the new medical head, UK and Ireland for the company’s Genzyme unit.

Views & Analysis

Future proofing the UK’s research ecosystem in the face of g...

The UK is a powerhouse of clinical research but maintaining that leading position – and all the benefits that come with it – in the face of global change requires adaptation.

Views & Analysis